However, adverse effects of JAK inhibitors such as blood clots and liver damage prompt the need to utilize natural substances with minimal side effects for control of the STAT pathway in inflammation, obesity, and cancer. The gene discussed is SOAT1; the disease is obesity due to melanocortin 4 receptor deficiency.